Henoch-Schönlein purpura nephritis: Pathophysiology, treatment, and future strategy

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 679-689

  Davin, Jean Claude ^a,b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; ECULIZUMAB; IMMUNOGLOBULIN A; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; MIZORIBINE; PREDNISONE; RITUXIMAB; UROKINASE;

ANAPHYLACTOID PURPURA; CELL ACTIVATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; COMPLEMENT ACTIVATION; DISEASE COURSE; DRUG MEGADOSE; FIBRIN FORMATION; GLOMERULOSCLEROSIS; HENOCH SCHONLEIN PURPURA NEPHRITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROGNOSIS; PROTEINURIA; REVIEW; TONSILLECTOMY; ANIMAL; EVIDENCE BASED MEDICINE; HOSPITALIZATION; KIDNEY; PATHOLOGY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ANIMALS; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY; NEPHRITIS; PATIENT SELECTION; PURPURA, SCHOENLEIN-HENOCH; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79953022603     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06710810     Document Type: Review

References (133)

1. Meadow SR, Scott DG: Berger disease: Henoch-Schönlein without the rash. J Pediatr 106: 27-32, 1985 (Pubitemid 15189903)
2. Davin JC, Ten Berge IJ, Weening JJ: What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59: 823-834, 2001
3. Haycock GB: The nephritis of Henoch-Schönlein purpura. In: Oxford Textbook of Clinical Nephrology, edited by Cameron S, Davison AM, Grünfeld JP, Oxford, Oxford University Press, 1992, pp 595-612
4. Broyer M: Fréquence et cause de l'insuffisance rénale chez l'enfant. In: Néphrologie Pédiatrique, edited by Royer P, Habib R, Mathieu H, Broyer M, Paris, Flammarion Médecine-Sciences, 1983, pp 425-433
5. Eleftheriou D, Brogan PA: Vasculitis in children. Best Pract Res Clin Rheumatol 23: 309-323, 2009
6. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33: 1114-1121, 1990
7. Rao JK, Allen NB, Pincus T: Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 129: 345-352, 1998
8. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR: Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360: 1197-1202, 2002
9. Dolezalova P, Telekesova P, Nemcova D, Hoza J: Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 31: 2295-2299, 2004 (Pubitemid 39453254)
10. Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, Chiang BL: A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan. Rheumatology 44: 618-622, 2005
11. Aalberse J, Dolman K, Ramnath G, Pereira RR, Davin JC: Henoch Schonlein purpura in children: An epidemiological study among Dutch paediatricians on incidence and diagnostic criteria. Ann Rheum Dis 66: 1648-1650, 2007 (Pubitemid 350205455)
12. White RHR, Yoshikawa N. Henoch-Schönlein nephritis. In: Pediatric Nephrology, edited by Barratt TM, Holiday M, Baltimore, Williams & Wilkins, 1993, pp 729-738
13. Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, Flageul B, Morel P, Rybojad M: Schönlein-Henoch purpura in adult patients: Predictive factors for IgA glomerulonephritis in a retrospective of 57 cases. Arch Dermatol 133: 438-442, 1997 (Pubitemid 27175691)
14. Goldstein AR, White RHR, Akuse R, Chantler C: Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339: 280-282, 1992
15. Koskimies O, Mir S, Rapola J, Vilska J: Henoch-Schönlein nephritis: Long-term prognosis of unselected patients. Arch Intern Med 56: 482-484, 1981 (Pubitemid 11046610)
16. Fogazzi GB, Pasquali S, Moriggi M, Casanova S, Damilano I, Mihatsch MJ, Zucchelli P, Ponticelli C: Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol 31: 60-66, 1989 (Pubitemid 19061038)
17. Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F: Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM 99: 253-265, 2006
18. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP: Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant 12: 2277-2283,1997 (Pubitemid 27474607)
19. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D: Henoch-Schönlein Purpura in adults: Outcome and prognostic factors. J Am Soc Nephrol 13: 1271-1278, 2002 (Pubitemid 34441408)
20. Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M, González-Gay MA: Henoch-Schönlein purpura in adulthood and childhood: Two different expressions of the same syndrome. Arthritis Rheum 40: 859-864, 1997 (Pubitemid 27200002)
21. Ronkainen J, Nuutinen M, Koskimies O: The adult kidney 24 years after childhood Henoch-Schönlein purpura: A retrospective cohort study. Lancet 360: 666-670, 2002 (Pubitemid 35232334)
22. Lau KK, Suzuki H, Novak J, Wyatt RJ: Pathogenesis of Henoch- Schönlein purpura nephritis. Pediatr Nephrol 25: 179-184, 2010
23. Levinsky RJ, Barratt TM: IgA immune complexes in Henoch-Schönlein purpura. Lancet 24: 1100-1103, 1979 (Pubitemid 10211491)
24. Kauffman RH, van Es LA, Daha MR: The specific detection of IgA in immune complexes. J Immunol Methods 40: 117-129, 1981
25. Davin JC, Pierard G, Dechenne C, Jansen F, Chantraine JM, Mahieu PR: Possible pathogenic role of IgE in Henoch-Schönlein purpura. Pediatr Nephrol 8: 169-171, 1994 (Pubitemid 24092251)
26. Allen AC, Willis FR, Beattie TJ, Feehally J: Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13: 930-934, 1998 (Pubitemid 28161766)
27. Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J: Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 22: 2067-2072, 2007 (Pubitemid 350090713)
28. Novak J, Moldoveanu Z, Renfrow MB,Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J: IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 157: 134-138, 2007
29. Suzuki H, Fan R, Zhang Z,Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak: Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119: 1668-1677, 2009
30. Davin JC, Forget P, Mahieu PR: Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Paediatr Scand 77: 118-124, 1988 (Pubitemid 18081555)
31. de Fijter JW, Eijgenraam JW, Braam CA,Holmgren J, Daha MR, van Es LA, van den Wall Bake AW: Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 50: 952-961, 1996 (Pubitemid 26302685)
32. Monteiro RC: The role of IgA and IgA Fc receptors in inflammation. J Clin Immunol 30[Suppl 1]: S61-S64, 2010
33. Emancipator SN: Primary and secondary forms of IgA nephritis and Schönlein-Henoch syndrome. In: Pathology of the Kidney, edited by Heptinstall RH, London, Little Brown, 1993, pp 389-476
34. Oortwijn BD,Roos A,Royle L,van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C: Differential glycosylation of polymeric and monomeric IgA: A Possible Role in Glomerular Inflammation in IgA Nephropathy. J Am Soc Nephrol 17: 3529-3539, 2006 (Pubitemid 44865296)
35. Chen A, Chen WP, Sheu LF, Lin CY: Pathogenesis of IgA nephropathy: In vitro activation of human mesangial cells by IgA. J Pathol 173: 119-126, 1994
36. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J: Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 153: 5247-5255, 1994 (Pubitemid 24983927)
37. Lopez-Armada MJ, Gomez-Guerrero C, Egido J: Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: Role of TGF-beta. J Immunol 157: 2136-2142, 1996 (Pubitemid 126449692)
38. Haas M: IgA nephropathy and Henoch-Schönlein purpura. In: Pathology of the Kidney, 6th Edition, edited by Jennette JC, Olson JL, Schwartz MM, Silva FG, Philadelphia, Lippincott Williams & Wilkins, 2007, 423-486
39. Hisano S, Matsushita M, Fujita T, Iwasaki H: Activation of the lectin complement pathway in Henoch-Schonlein purpura nephritis. Am J Kidney Dis 45: 295-302, 2005 (Pubitemid 40431055)
40. Roos A,Rastaldi MP,Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha: Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17: 1724-1734, 2006 (Pubitemid 43794676)
41. Davies M: The mesangial cell: A tissue culture view. Kidney Int 45: 320-327, 1994
42. Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, Kobayashi K, Su S, Mukaida N, Matsushima K: Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukocyte Biol 63: 493-499, 1998 (Pubitemid 28163190)
43. Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143: 3949-3955,1989 (Pubitemid 20012578)
44. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H, Kurokawa KL: Glomerular FcaR expression and disease activity in IgA nephropathy. Am J Kidney Dis 30: 389-396, 1997 (Pubitemid 27391508)
45. Terada Y, Yamada T, Nakashima O, Sasaki S, Nonoguchi H, Tomita K, Marumo F: Expression of PDGF and PDGF receptor mRNA in in IgA nephropathy. J Am Soc Nephrol 8: 817-819, 1997 (Pubitemid 27493597)
46. Niemir ZI, Stein H, Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48: 1530-1541, 1995
47. Schlöndorff D, Banas B: The mesangial cell revisited: No cell is an island. J Am Soc Nephrol 20: 1179-1187, 2009
48. Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, Lou T, Zhang H: Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulate transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation. Arch Med Res 41: 255-260, 2010
49. Hara M, Yanagihara T, Kihara I: Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis. Clin J Am Soc Nephrol 2: 231-238, 2007
50. Couser, WG: Glomerulonephritis. Lancet 353: 1509-1515, 1999
51. Jennette JC: Rapidly progressive crescentic glomerulonephritis. Kidney Int 63: 1164-1177, 2003
52. Cunningham MA, Kitching AR, Tipping PG, Holdsworth SR: Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis. Kidney Int 66: 647-657, 2004
53. Habib R: Purpura Rhumatoïde. In: Néphrologie Pédiatrique, edited by Royer P, Habib R, Mathieu H, Broyer M, Paris, Flammarion Médecine-Sciences, 1983, pp 342-350
54. Meadow SR, Glasgow EF, White RH, Moncrieff MW, Cameron JS, Ogg CS: Schönlein-Henoch nephritis. QJM 41: 241-258,1972
55. Yoshikawa N, White RH, Cameron AH: Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis. Clin Nephrol 16: 223-229, 1981 (Pubitemid 11027944)
56. Shenoy M, Bradbury MG, Lewis MA, Webb NJ: Outcome of Henoch- Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 22: 1717-1722, 2007 (Pubitemid 47337426)
57. Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F: Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 13: 816-823, 1999
58. Schillinger F, Denis PS, Dion JJ, Montagnac R, Melin JP, Milcent T, Beghoura R, Birembaut P, Chanard J: Severe Schonlein-Henoch nephritis in adults: A report of twenty cases. Nephrologie 21: 247-252, 2000
59. Heaton JM, Turner DR, Cameron JS: Localization of glomerular "deposits" in Henoch-Schönlein nephritis. Histopathology 1: 93-104, 1977
60. Szeto CC, Choi PC, To KF, Li PK, Hui J, Chow KM, Leung CB, Lui SF, Mac-Moune Lai F: Grading of acute and chronic renal lesions in Henoch-Schönlein purpura. Mol Pathol 14: 635-640, 2001 (Pubitemid 32667206)
61. Bonsib S: Glomerular basement membrane discontinuities: Scanning electron microscopic study of acellular glomeruli. Am J Pathol 119: 357-360, 1985
62. Kincaid-Smith P, Nicholls K, Birchall I: Polymorphs infiltrate glomeruli in mesangial IgA glomerulonephritis. Kidney Int 36: 1108-1111, 1989 (Pubitemid 20049220)
63. Emancipator SN: IgA nephropathy: Morphologic expression and pathogenesis. Am J Kidney Dis 23: 451-462, 1994
64. Vassalli P, McCluskey RT: The pathogenetic role of the coagulation process in rabbit Masugi nephritis. Am J Pathol 45: 653-661, 1964
65. Mathieson PW: The ins and outs of glomerular crescent formation. Clin Exp Immunol 110: 155-157, 1997
66. Nishikawa K, Guo YJ, Miyasaka M, Tamatani T, Collins AB, Sy MS, McCluskey RT, Andres G: Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 177: 667-677, 1993 (Pubitemid 23104278)
67. Adler S, Brady HR: Cell adhesion molecules and the glomerulopathies. Am J Med 107: 371-386, 1999 (Pubitemid 29465816)
68. Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC: Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 47: 1303-1309, 1995
69. Lan HY, Yang N, Metz C, Mu W, Song Q, Nikolic-Paterson DJ, Bacher M, Bucala R, Atkins RC: TNF-alpha upregulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3: 136-144, 1997 (Pubitemid 27229841)
70. Khan SB, Cook HT, Bhangal G, Smith J, Tam FW, Pusey CD: Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 67: 1812-1820, 2005
71. Border WA, Noble NA: Transforming growth factor in tissue fibrosis: N Engl J Med 331: 1286-1292, 1994 (Pubitemid 24333194)
72. Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA, Noble NA, Kaneda Y, Hori M, Imai E: Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55: 465-475, 1999 (Pubitemid 29082873)
73. Morel-Maroger Striker L, Killen PD,Chi E, Striker GE: The composition of glomerulosclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest 51: 181-192, 1984
74. Lan HY, Nikolic-Paterson DJ, Atkins RC: Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and crescent progression in experimental glomerulonephritis. Lab Invest 67: 743-751, 1992 (Pubitemid 23024624)
75. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY: Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 7: 2271-2278, 1996 (Pubitemid 27465931)
76. Smith J, Lai PC, Behmoaras J, Roufosse C, Bhangal G, McDaid JP, Aitman T, Tam FW, Pusey CD, Cook HT: Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J Am Soc Nephrol 18: 1816-1823, 2007
77. Mc Lean RH, Michael AF, Fish AJ, Vernier RL: Anaphylactoid purpura. In: Pediatric Nephrology, edited by Rubin MI, Barratt TM, Baltimore, Williams & Wilkins, 1975, pp 584-588
78. Van Es LA, Kauffmann RH, Valentijn RM: Henoch-Schönlein Purpura. In: Pediatric Nephrology, edited by Holliday MA, Barratt TM, Vernier RL, Baltimore, Williams & Wilkins, 1987, pp 492-498
79. Meadow SR: Schönlein-Henoch Syndrome. In: Pediatric Kidney Disease, edited by Edelman CM, London, Little, Brown and Company, 1992, pp 1525-1533
80. Rees L, Webb NJA, Brogan PA: Henoch-Schönlein purpura. In: Paediatric Nephrology, edited by Rees L, Webb NJA, Brogan PA, Oxford, Oxford University Press, 2007, pp 312-313
81. Coppo R, Amore A: Henoch-Schönlein purpura. In: Pediatric Nephrology, edited by Avner ED, Harmon WE, Niaudet P, Philadelphia, Lippincott Williams & Wilkins, 2004, pp 851-864
82. Araque A, Sánchez R, Alamo C, Torres N, Praga M: Evolution of immunoglobulin A nephropathy into Henoch-Schönlein purpura in an adult patient. Am J Kidney Dis 25: 340-342,1995
83. Hughes FJ, Wolfish NM, McLaine PN: Henoch-Schönlein syndrome and IgA nephropathy: A case report suggesting a common pathogenesis. Pediatr Nephrol 2: 389-392, 1988
84. Silverstein DM, Greifer I, Folkert V, Bennett B, Corey HE, Spitzer A: Sequential occurrence of IgA nephropathy and Henoch-Schönlein purpura: Support for common pathogenesis. Pediatr Nephrol 8: 752-753, 1994
85. Ravelli A, Carnevale-Maffe G, Ruperto N, Ascari E, Martini A: IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. Nephron 72: 111-112, 1996 (Pubitemid 26009484)
86. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C: Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2: 11-14, 1977
87. Niaudet P, Murcia I, Beaufils H, Broyer M, Habib R: Primary IgA nephropathies in children: Prognosis and Treatment. Adv Nephrol Necker Hospital 22: 121-140, 1993
88. Bunchman TE, Mauer SM, Sibley RK, Vernier RL: Anaphylactoid purpura: Characteristics of 16 patients who progressed to renal failure. Pediatr Nephrol 2: 393-397, 1988
89. Nussinovitch N, Elishkevitz K, Volovitz B, Nussinovitch M: Hypertension as a late sequela of Henoch-Schönlein purpura. Clin Pediatr 44: 543-547, 2005 (Pubitemid 40967698)
90. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L: Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 47: 993-997, 2006
91. Tarshish P, Bernstein J, Edelmann CM Jr: Henoch-Schönlein purpura nephritis: Course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 19: 51-56, 2004 (Pubitemid 38088250)
92. Soylemezoglu O, Ozkaya O, Ozen S, Bakkaloglu A, Dusunsel R, Peru H, Cetinyurek A, Yildiz N, Donmez O, Buyan N, Mir S, Arisoy N, Gur-Guven A, Alpay H, Ekim M, Aksu N, Soylu A, Gok F, Poyrazoglu H, Sonmez F, Turkish Pediatric Vasculitis Study Group: Henoch-Schönlein nephritis: A nationwide study. Nephron Clin Pract 112: 199-204, 2009
93. Pillebout E, Alberti C, Guillevin L, Ouslimani A, Thervet E: Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura. Kidney Int 78: 495-502, 2010
94. Bennett WM, Kincaid-Smith P: Macroscopic hematuria in mesangial nephropathy: Correlation with glomerular crescents and renal dysfunction. Kidney Int 23: 392-400, 1983
95. A Working Group of the International IgA Nephropathy Network, the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76: 534-545, 2009
96. Zaffanello M, Fanos V: Treatment-based literature of Henoch- Schönlein purpura nephritis in childhood. Pediatr Nephrol 24: 1901-1911, 2009
97. Chartapisak W, Opastirakul S, Hodson EM, Willis NS, Craig JC: Interventions for preventing and treating kidney disease in Henoch- Schönlein Purpura (HSP). Cochrane Database Syst Rev. 3: CD005128, 2009
98. Bogdanović R: Henoch-Schönlein purpura nephritis in children: Risk factors, prevention and treatment. Acta Paediatr 98: 1882-1889, 2009
99. Donnithorne KJ, Atkinson TP, Hinze CH, Nogueira JB, Saeed SA, Askenazi DJ, Beukelman T, Cron RQ: Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura. J Pediatr 155: 136-139, 2009
100. Donghi D, Schanz U, Sahrbacher U, Recher M, Trüeb RM, Müllhaupt B, French LE, Hafner J: Life-threatening or organ-impairing Henoch-Schönlein purpura: Plasmapheresis may save lives and limit organ damage. Dermatology 219: 167-170, 2009
101. Acar B, Arikan FI, Alioglu B, Oner N, Dallar Y: Successful treatment of gastrointestinal involvement in Henoch-Schönlein purpura with plasmapheresis. Pediatr Nephrol 23: 2103, 2008
102. Lee J, Clayton F, Shihab F, Goldfarb-Rumyantzev A: Successful treatment of recurrent Henoch-Schönlein purpura in a renal allograft with plasmapheresis. Am J Transplant 8: 228-231, 2008
103. Wortmann SB, Fiselier TJ, Van De Kar NC, Aarts RA, Warris A, Draaisma JM: Refractory severe intestinal vasculitis due to Henoch-Schönlein purpura: Successful treatment with plasmapheresis. Acta Paediatr 95: 622-623, 2006 (Pubitemid 43791588)
104. Rech J, Fuchs F, Kallert S, Hueber AJ, Requadt C, Manger B, Kalden JR, Amann K, Strauss R, Schulze-Koops H: Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement. Clin Rheumatol 26: 112-114, 2007 (Pubitemid 46020037)
105. Wen YK, Yang Y, Chang CC: Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schönlein purpura treated with plasmapheresis. Pediatr Nephrol 20: 223-225, 2005 (Pubitemid 40174040)
106. Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, Suzuki S, Suzuki H: Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis. Pediatr Nephrol 19: 920-923, 2004 (Pubitemid 39144779)
107. Eun SH, Kim SJ, Cho DS, Chung GH, Lee DY, Hwang PH: Cerebral vasculitis in Henoch-Schönlein purpura: MRI and MRA findings, treated with plasmapheresis alone. Pediatr Int 45: 484-487, 2003 (Pubitemid 37129941)
108. Chen CL, Chiou YH, Wu CY, Lai PH, Chung HM: Cerebral vasculitis in Henoch-Schönlein purpura: A case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatr Nephrol 15: 276-278, 2000
109. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M: Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. Am J Kidney Dis 33: 427-433, 1993
110. Shenoy M, Ognjanovic MV, Coulthard MG: Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 22: 1167-1171, 2007
111. Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet 373: 759-767, 2009
112. Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, Gaya A, Coyle L, de Castro C, Fu CL, Maciejewski JP, Bessler M, Kroon HA, Rother RP, Hillmen P: Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 15: 1840-1847, 2008
113. Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T: Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Am J Kidney Dis 55: 708-711, 2010
114. Gruppo RA, Rother RP: Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med 360: 544-546, 2009
115. Nürnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M: Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med 360: 542-544, 2009
116. Coppo R, Amore A, Gianoglio B, Cacace G, Picciotto G, Roccatello D, Peruzzi L, Piccoli G, De Filippi PG: Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis 21: 593-602, 1993 (Pubitemid 23178474)
117. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G: Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64: 149-159, 2003 (Pubitemid 36714167)
118. Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T on behalf of the EC Biomed Concerted Action Project BMH4-97-2487(DG 12-SSMI) and IgACE European Collaborative Group003: IgACE: A placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18: 1880-1888, 2007
119. Kanno Y, Okada H, Yamaji Y, Nakazato Y, Suzuki H: Angiotensin- converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. QJM 98: 199-203, 2005 (Pubitemid 40361317)
120. Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F: Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol 15: 157-163, 2004 (Pubitemid 38020707)
121. Ronkainen J, Autio-Harmainen H, Nuutinen M: Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. J Pediatr Nephrol 18: 1138-1142, 2003 (Pubitemid 37406861)
122. Ronkainen J, Ala-Houhala M, Antikainen M: Cyclosporine A (CyA) versus MP pulses (MP) in the treatment of severe Henoch- Schonlein Nephritis (HSN). Pediatr Nephrol 21: 1531, 2006
123. Ou ZL, Nakayama K, Natori Y, Doi N, Saito T, Natori Y: Effective methylprednisolone dose in experimental crescentic glomerulonephritis. Am J Kidney Dis 37: 411-417, 2001 (Pubitemid 32116035)
124. Niaudet P, Habib R: Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12: 238-243, 1998 (Pubitemid 28204133)
125. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H: Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. Pediatrics 111: 785-789, 2003 (Pubitemid 36402902)
126. Andersen RF, Rubak S, Jespersen B, Rittig S: Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome. Scand J Urol Nephrol 43: 409-415, 2009
127. Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB: Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 21: 128-133, 2001 (Pubitemid 32453691)
128. Kawasaki Y, Suyama K, Hashimoto K, Hosoya M: Methylprednisolone pulse plus mizoribine in children with Henoch- Schoenlein purpura nephritis. Clin Rheumatol 2010, Sep 16. [Epub ahead of print]
129. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N: Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol; 12: 244-248, 1998
130. Bergstein J, Leiser J, Andreoli SP: Response of crescentic Henoch Schoelein purpura nephritis to corticosteroids and azathioprine therapy. Clin Nephrol 49: 9-14, 1998 (Pubitemid 28043360)
131. Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM, Medsger TA Jr, Ramsey-Goldman R: Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum 39: 1178-1188, 1996 (Pubitemid 26240232)
132. Branten AJ, Kock-Jansen M, Klasen IS, Wetzels JF: Urinary excretion of complement C3d in patients with renal diseases. Eur J Clin Invest 33: 449-456, 2003 (Pubitemid 36754208)
133. Bitzan M, Anselmo M, Carpineta L: Rituximab (B-cell depleting antibody) associated lung injury (RALI): A pediatric case and systematic review of the literature. Pediatr Pulmonol 44: 922-934, 2009